Pfizer - Articles and news items

Pfizer collaboration to reduce injectable contraceptive price

Industry news / 22 May 2017 / Niamh Marriott, Junior Editor

Pfizer have announced an extension of their collaboration to further broaden access to Pfizer’s all-in-one injectable contraceptive…

Sangamo and Pfizer to collaborate on Haemophilia A gene therapy

Industry news / 17 May 2017 / Niamh Marriott, Junior Editor

Sangamo and Pfizer have announced a global collaboration and license agreement for the development of gene therapy programs for Haemophilia A…

Relocating the EMA: An open letter from EFPIA and Pharma Heads of Research

Industry news / 16 May 2017 / European Federation of Pharmaceutical Industries and Associations (EFPIA)

The EMA is a world class regulator, whose scientific recommendations are a vital element of the ongoing effort to provide EU citizens with quality medicines

Pfizer’s Phase III study to treat hospital-acquired pneumonia a success

Industry news / 25 April 2017 / Niamh Marriott, Junior Editor

Pfizer’s results show patients diagnosed with hospital-acquired pneumonia (HAP) treated with Zavicefta or Meropenem experienced comparable rates of cure…

2017 Pipelines: Drugs to watch

Blog, Z Homepage promo / 12 April 2017 / Alexandra Kibble, Senior Editor, Clarivate Analytics Cortellis

The annual Drugs to Watch report forecasts that eight new drugs will enter the market in 2017 and achieve blockbuster sales of >$900 billion by 2021…

immunogenicity

Injectable drug delivery market worth US$624.50 billion by 2021

Industry news / 23 March 2017 / Niamh Marriott, Junior Editor

According to a new report, the global injectable drug delivery market is projected to reach US$624.50 Billion by 2021 from US$362.38 billion in 2016…

Crohn’s disease

Celltrion Healthcare & Pfizer’s biosimilar shows positive results in Crohn’s disease study

Industry news / 20 February 2017 / Niamh Marriott, Digital Editor

Celltrion Healthcare presented the primary outcome from its pivotal randomised controlled trial of CT-P13 (biosimilar infliximab) in Crohn’s disease.

The Top 21…wealthiest pharma companies

Blog, Z Homepage promo / 6 February 2017 / Niamh Marriott, Digital Editor

Find out who made it to the top of our list of richest pharma companies…

Pfizer’s breast cancer drug too expensive for NHS

Industry news / 3 February 2017 / Niamh Marriott, Digital Editor

NICE has today published draft guidance which does not recommend Pfizer’s breast cancer drug palbociclib for routine funding on the NHS…

Pfizer fined £85 million for 2600% drug price increase to NHS

Industry news, Z Homepage promo / 9 December 2016 / Niamh Louise Marriott, Digital Editor

Pharma Giant Pfizer has been fined a record £84.2 million after it broke competition law by charging excessive and unfair prices to the UK…

ViiV Healthcare to evaluate injectable HIV treatment

Industry news / 23 November 2016 / Niamh Louise Marriott, Digital Content Producer

The two studies, FLAIR and ATLAS, will examine the safety and efficacy of monthly dosing with the two-drug, injectable regimen in both treatment-naïve…

Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compression

Webinars, Z Homepage promo / 19 October 2016 / Viavi

In this webinar, experts from Viavi, Pfizer & Université Laval discussed how MicroNIR is used to optimise fluid bed drying and to reduce waste at tablet compression…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+